Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM6WT8Agents primarily affecting blood constituents or immune system
Enzymes

XM35D2 category

Protein C

Also indexed as

Protein C

Nearby in Enzymes

XM6Y81Alidase
XM0KX8Alpha amylase
XM7NZ6Chymotrypsin
XM8P48Cocarboxylase
XM1819Deoxyribonuclease
XM3HF5Diffusin
XM3TF2Enzyme fibrolytic
XM5GS9Enzyme thrombolytic

PreviousXM5ZA2 — Tenecteplase NextXM32Y3 — Fibrinolysin and desoxyribonuclease

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM3MU3Agents primarily affecting the gastrointestinal system
XM6WT8Agents primarily affecting blood constituents or immune system
XM3KY1Agents affecting genitourinary system, sex or anabolic hormones
XM26S4Hormones and their synthetic substitutes or antagonists, not elsewhere classified
XM9W63Agents affecting bones, joints or other connective tissue, not elsewhere classified
XM4TG8Agents primarily affecting water and nutrition-balance or metabolism
XM3973Agents primarily affecting the cardiovascular system
XM6CH2Drugs primarily affecting the autonomic nervous system
XM7YD4Drugs used in addictive disorders
14 more
Other fibrinolysis-affecting drugs
Anticoagulant antagonists, vitamin K and other coagulants
Natural blood and blood products
Iron and its compounds
Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
Enzymes
Drugs used in hereditary angioedema
Local hemostatics
Other haematological agents
4 more
XM2P48Pancreatic dornase
XM9J86Penicillinase
XM52N4Pronase
XM94J1Serrapeptase
XM93U7Streptodornase
XM8183Sutilains
XM40V6Trypsin
XM6RN7Reteplase
XM04S7Saruplase
XM8K47Drotrecogin alfa (activated)
XM5ZA2Tenecteplase
XM35D2Protein C
XM32Y3Fibrinolysin and desoxyribonuclease
XM4XM2Fibrinolysin
XM9PZ9Tissue plasminogen activator
9 more

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact